D Dubois-Laforgue
Overview
Explore the profile of D Dubois-Laforgue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
423
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mifsud F, Saint-Martin C, Dubois-Laforgue D, Bouvet D, Timsit J, Bellanne-Chantelot C
Diabetes Res Clin Pract
. 2022 May;
188:109908.
PMID: 35533745
Aim: Identification of monogenic diabetes (MgD) conveys benefits for patients' care. Algorithms for selecting the patients to be genetically tested have been established in EuroCaucasians, but not in non-EuroCaucasian individuals....
2.
Briere M, Diedisheim M, Dehghani L, Dubois-Laforgue D, Larger E
Diabetes Metab
. 2020 May;
47(1):101164.
PMID: 32461154
Background: Anaemia is frequently seen in patients with diabetes and the main cause is renal failure. At all stages of renal failure, however, the prevalence of anaemia is higher in...
3.
Sola-Gazagnes A, Faucher P, Jacqueminet S, Ciangura C, Dubois-Laforgue D, Mosnier-Pudar H, et al.
Diabetes Metab
. 2019 Aug;
46(2):158-163.
PMID: 31415813
Objective: Continuous glucose monitoring tends to replace capillary blood glucose (CBG) self-monitoring. Our aim was to determine the agreement between CBG and a flash glucose monitoring system (Flash-GMS) in treatment...
4.
Lepercq J, Le Ray C, Godefroy C, Pelage L, Dubois-Laforgue D, Timsit J
Diabetes Metab
. 2018 May;
45(2):191-196.
PMID: 29776801
Aim: This study assessed pregnancy outcomes in women with type 1 diabetes (T1D) over the last 15 years and identified modifiable factors associated with good perinatal outcomes. Methods: Pregnancy outcomes...
5.
Dubois-Laforgue D, Bellanne-Chantelot C, Charles P, Jacquette A, Larger E, Ciangura C, et al.
Diabetes Metab
. 2016 Nov;
43(1):89-92.
PMID: 27838256
No abstract available.
6.
Bellanne-Chantelot C, Coste J, Ciangura C, Fonfrede M, Saint-Martin C, Bouche C, et al.
Diabetes Metab
. 2015 Mar;
42(1):33-7.
PMID: 25753245
Aim: Low plasma levels of high-sensitivity C-reactive protein (hs-CRP) have been suggested to differentiate hepatocyte nuclear factor 1 alpha-maturity-onset diabetes of the young (HNF1A-MODY) from type 2 diabetes (T2D). Yet,...
7.
Dubois-Laforgue D, Boutboul D, Levy D, Joly D, Timsit J
Diabetes Res Clin Pract
. 2014 Jan;
103(3):e53-5.
PMID: 24447807
We report two patients with diabetes in whom acute renal failure requiring hemodialysis occurred while on treatment with glucagon-like peptide-1 receptor agonists. We discuss the mechanisms of this complication and...
8.
Wilmot-Roussel H, Levy D, Carette C, Caillat-Zucman S, Boitard C, Timsit J, et al.
Diabetes Metab
. 2013 Mar;
39(3):244-9.
PMID: 23522731
Aim: Glutamic acid decarboxylase (GAD) and/or islet antigen-2 (IA-2) autoantibodies (ab) are present in 90% of patients at the onset of type 1 diabetes (T1D). Few studies have shown that...
9.
Ferrarezi D, Bellili-Munoz N, Dubois-Laforgue D, Cheurfa N, Lamri A, Reis A, et al.
Diabetes Metab
. 2013 Jan;
39(3):263-70.
PMID: 23352876
Aim: Vitamin D deficiency is associated with coronary artery disease (CAD), and the actions of vitamin D are mediated by binding to a specific nuclear vitamin D receptor (VDR). This...
10.
Scotto M, Afonso G, Larger E, Raverdy C, Lemonnier F, Carel J, et al.
Diabetologia
. 2012 Apr;
55(7):2026-31.
PMID: 22526607
Aims/hypothesis: Anti-zinc transporter (ZnT)8 autoantibodies are commonly detected in type 1 diabetic patients. We hypothesised that ZnT8 is also recognised by CD8(+) T cells and aimed to identify HLA-A2 (A*02:01)-restricted...